查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1951178

微流體元件市場－全球產業規模、佔有率、趨勢、機會及預測（依產品、產業、區域及競爭格局分類，2021-2031年）

Microfluidic Components Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Industry, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 181 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球微流體元件市場預計將從 2025 年的 59.1 億美元成長到 2031 年的 100.7 億美元，複合年成長率達到 9.29%。

這些組件由微型幫浦、閥門、晶片和感測器等專用精密元件組成，旨在實現對亞毫米級微通道內流體的操控。市場成長的主要驅動力是照護現場(POC) 需求的不斷成長以及高通量篩檢在藥物研發中日益廣泛的應用。這些領域依賴微流體系統來最大限度地減少樣本用量並加快分析速度，從而促進個人化醫療的發展。 SEMI 的報告反映了這一強勁的需求，報告指出，作為微流體造基礎的 MEMS 和感測器的全球晶圓廠資本支出將在 2024 年達到約 120 億美元的歷史新高。

市場概覽
預測期 2027-2031
市場規模：2025年 59.1億美元
市場規模：2031年 100.7億美元
複合年成長率：2026-2031年 9.29%
成長最快的細分市場 微型針
最大的市場 北美洲

儘管市場成長迅速，但仍面臨一項重大挑戰：組件間介面缺乏標準化，導致模組化零件難以組裝成整合系統。這種碎片化會阻礙大規模擴充性，並增加尋求建造互通解決方案的製造商的開發成本。此外，醫療設備認證的嚴格法規結構延長了產品開發週期，有可能延緩先進微流體技術的商業化應用。

市場促進因素

隨著醫療系統日益重視快速、分散的檢測方案，照護現場（POC）設備需求的不斷成長成為全球微流體組件市場的關鍵驅動力。微流體技術對於最大限度地減少試劑用量、將複雜的檢測功能整合到攜帶式晶片上至關重要，從而能夠在傳統醫院環境之外實現即時臨床決策。這種向模組化診斷平台的轉變，持續推動著對能夠高精度處理亞微升液體的精密微型幫浦和感測器的需求。生物梅里埃公司於2025年11月發布的《2025年第三季業務回顧》充分展現了這項促進因素的商業性實力。報告顯示，該公司基於微流體技術的SPOTFIRE系統實現了114%的年成長，全球裝置容量超過5,500台。

同時，微流體技術在藥物發現和高通量篩檢的應用日益廣泛，尤其是在基因組學和空間生物學領域，這為市場帶來了新的機會。製藥研究人員正利用微流體晶片實現樣品製備的自動化，並進行高解析度的單細胞分析，從而在降低營運成本的同時加速標靶識別。這一應用在領先創新企業的財務表現中得到了充分體現。例如，10x Genomics在2025年11月發布的「2025年第三季」財務報告中指出，受組織分析工具強勁需求的推動，其空間分析耗材收入成長了19%，達到3540萬美元。此外，Standard BioTools在2025年1月宣布，預計年銷售額將達到約1.74億美元，進一步印證了生物醫學研究領域對先進微流體技術的持續依賴。

市場挑戰

微流體元件市場擴充性和商業性化成熟的一大障礙是缺乏標準化的元件介面。目前，該產業面臨設計通訊協定碎片化的挑戰，各製造商生產的微型泵浦、閥門和感測器均採用專有的連接方式，導致彼此產品互不相容。這種缺乏通用標準的現狀迫使開發人員耗費大量時間和金錢進行客製化，才能將不同的元件整合到功能系統中。由此導致的「即插即用」互通性的缺失，阻礙了大規模生產的效率，推高了單位成本，並將該技術限制在小眾應用領域，從而阻礙了其廣泛的商業性化應用。

這種技術碎片化直接阻礙了市場成長，限制了半導體產業在整個生態系統中利用大規模生產能力的能力。儘管製造工廠配備了大規模生產所需的設備，但由於無法實現微流體設計的標準化，造成了瓶頸，限制了產能，並延緩了診斷解決方案的上市時間。根據SEMI預測，到2024年，全球半導體製造能力預計將成長6.4%，月產量將超過3,000萬片晶圓。這凸顯了由於這些整合挑戰，微流體開發人員仍然難以獲得龐大的工業規模。如果沒有一個統一的介面框架來簡化組裝並降低開發複雜性，市場就無法充分利用現有的製造基礎設施來滿足不斷成長的全球需求。

市場趨勢

器官晶片（OoC）模型的商業化程度不斷提高，為藥物安全性測試提供了一種生理學上精確的動物實驗替代方案，從而正在改變微流體市場。這一趨勢的驅動力在於市場對高保真人體組織模型的需求，這些模型能夠可靠地預測藥物療效，並減少代價高昂的臨床試驗失敗。為了應對這一需求，開發人員正在設計整合式高通量系統，以簡化用於常規工業應用的3D微組織的培養和分析。為了展示這種向可擴展平台的轉變，CN Bio在2025年10月的新聞稿「CN Bio推出整合式器官晶片平台」中宣布推出其PhysioMimix Core系統。該系統支援同時對多達288個樣本進行高通量篩檢，從而加速藥物研發進程。

同時，用於連續監測的穿戴式微流體生物感測器的興起，正將這項技術拓展到個人化醫療保健和工業安全領域。與靜態的照護現場診斷測試不同，這些非侵入式設備利用複雜的微通道即時採集和分析汗液和組織間液，從而動態地提供諸如水合水平和電解質平衡等生物標記的資訊。這項技術吸引了大量投資，用於擴大生產規模，並將基於雲端的分析功能整合到從精英運動員表現到遠端患者監護等各種應用中。 MobiHealthNews 在 2025 年 2 月發表的一篇題為《Epicore Biosystems資金籌措2600 萬美元以擴展汗液感測穿戴式技術》的報導中指出，Epicore Biosystems 已獲得 2600 萬美元的 B 輪資金籌措，用於在全球範圍內推廣其基於微流體技術的補水和代謝資金解決方案，這表明其基於微流控技術的補水和代謝資金。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球微流體元件市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品（閥門（電磁閥、流量控制閥、止回閥、梭閥、洩壓閥、比例閥、其他閥門）、流量/壓力控制器、流量/壓力感測器、微型幫浦、噴嘴、微針等）
    • 按產業分類（石油和天然氣、醫療、航太和國防、消費性電子、汽車、其他產業）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美微流體元件市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲微流體元件市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區微流體元件市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東和非洲微流體元件市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

10. 南美洲微流體元件市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球微流體元件市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Parker Hannifin Corporation
  • IDEX Corporation
  • Fluigent SA
  • Staiger GmbH & Co. KG
  • SMC Corporation
  • Camozzi Automation Spa Societa Unipersonale
  • Aignep spa
  • FIM Valvole Srl
  • Humphrey Products Corporation
  • Dolomite Microfluidics
  • Cellix Ltd.
  • Christian BUrkert GmbH & Co. KG

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 20060

The Global Microfluidic Components Market is projected to expand from USD 5.91 Billion in 2025 to USD 10.07 Billion by 2031, achieving a CAGR of 9.29%. These components, comprising specialized precision devices such as micropumps, valves, chips, and sensors, are engineered to manipulate and control fluids within sub-millimeter microchannels. Market growth is primarily driven by the rising demand for point-of-care diagnostics and the increasing application of high-throughput screening in pharmaceutical research. These sectors depend on microfluidic systems to minimize sample volume requirements and expedite analysis, thereby facilitating the transition toward personalized medicine. Reflecting this robust demand, SEMI reported in 2024 that global fab equipment spending for MEMS and sensors-a fundamental category for microfluidic manufacturing-reached a record high of approximately $12 billion.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 5.91 Billion
Market Size 2031USD 10.07 Billion
CAGR 2026-20319.29%
Fastest Growing SegmentMicroneedles
Largest MarketNorth America

Despite this growth, the market encounters a major challenge due to the lack of standardization across component interfaces, which complicates the integration of modular parts into unified systems. This fragmentation can impede mass scalability and inflate development costs for manufacturers striving to build interoperable solutions. Furthermore, rigorous regulatory frameworks regarding medical device approval can extend product development cycles, potentially delaying the commercial introduction of advanced microfluidic technologies.

Market Driver

The growing demand for point-of-care (POC) diagnostic devices acts as a primary catalyst for the Global Microfluidic Components Market, as healthcare systems increasingly favor rapid, decentralized testing options. Microfluidic technologies are critical for minimizing reagent usage and incorporating complex laboratory functions onto portable chips, enabling immediate clinical decision-making outside conventional hospital environments. This shift toward modular diagnostic platforms generates a consistent need for precision micropumps and sensors capable of handling sub-microliter volumes with high accuracy. The commercial strength of this driver is highlighted by bioMerieux's 'Third-Quarter 2025 Business Review' from November 2025, which noted that the company's microfluidic-based SPOTFIRE system achieved a 114% organic sales increase year-on-year, expanding its global installed base to over 5,500 instruments.

Concurrently, the increasing application of microfluidics in drug discovery and high-throughput screening is broadening market opportunities, especially within genomics and spatial biology. Pharmaceutical researchers utilize microfluidic chips to automate sample preparation and perform single-cell analysis with high resolution, speeding up target identification while lowering operational costs. This adoption is evident in the financial results of leading innovators; for instance, 10x Genomics reported in their 'Third Quarter 2025 Financial Results' in November 2025 that revenue for spatial consumables rose by 19% to $35.4 million, driven by strong demand for tissue analysis tools. Additionally, Standard BioTools reported preliminary full-year revenue of roughly $174 million in January 2025, underscoring the persistent industrial reliance on advanced microfluidic technologies for biomedical research.

Market Challenge

The absence of standardization across component interfaces poses a significant barrier to the scalability and commercial maturation of the microfluidic components market. Currently, the industry struggles with fragmented design protocols, where manufacturers produce micropumps, valves, and sensors with proprietary connections that are incompatible with those of other vendors. This lack of universal standards compels developers to undertake expensive and time-consuming customization efforts to combine disparate parts into functional systems. Consequently, the lack of "plug-and-play" interoperability prevents the efficiencies typically associated with mass production, keeping unit costs high and limiting the technology to niche applications rather than widespread commercial adoption.

This technical fragmentation directly hampers market growth by restricting the industry's ability to leverage the high-volume manufacturing capabilities of the broader semiconductor ecosystem. Although fabrication facilities are equipped for massive output, the inability to standardize microfluidic designs creates a bottleneck that limits throughput and delays time-to-market for diagnostic solutions. According to SEMI, in 2024, global semiconductor manufacturing capacity grew by 6.4 percent to exceed 30 million wafers per month, highlighting the immense industrial scale that remains largely inaccessible to microfluidic developers due to these integration challenges. Without a unified interface framework to streamline assembly and reduce development complexity, the market cannot fully capitalize on existing manufacturing infrastructure to meet rising global demand.

Market Trends

The increasing commercialization of organ-on-chip (OoC) models is reshaping the microfluidic components market by offering physiologically accurate alternatives to animal testing for pharmaceutical safety. This trend is fueled by the demand for high-fidelity human tissue models that can reliably predict drug efficacy, thereby reducing expensive clinical failures. Developers are responding by engineering integrated, high-throughput systems that streamline the culture and analysis of 3D microtissues for routine industrial use. Demonstrating this shift toward scalable platforms, CN Bio announced in their October 2025 press release, 'CN Bio Launches Unified Organ-on-a-Chip Platform,' the introduction of its PhysioMimix Core system, which supports high-throughput screening of up to 288 samples simultaneously to accelerate drug discovery pipelines.

Simultaneously, the rise of wearable microfluidic biosensors for continuous monitoring is expanding the technology into personalized health and industrial safety sectors. Unlike static point-of-care diagnostic tests, these non-invasive devices employ complex micro-channels to capture and analyze sweat or interstitial fluid in real-time, providing dynamic insights into biomarkers such as hydration levels and electrolyte balance. This capability is attracting significant investment to scale manufacturing and integrate cloud-based analytics for applications ranging from elite sports performance to remote patient monitoring. Highlighting the robust financial confidence in this sector, MobiHealthNews reported in February 2025, in the article 'Epicore Biosystems scores $26M to expand sweat-sensing wearable technology,' that Epicore Biosystems secured $26 million in Series B funding to scale its microfluidic hydration and metabolic health solutions globally.

Key Market Players

  • Parker Hannifin Corporation
  • IDEX Corporation
  • Fluigent SA
  • Staiger GmbH & Co. KG
  • SMC Corporation
  • Camozzi Automation Spa Societa Unipersonale
  • Aignep s.p.a.
  • FIM Valvole Srl
  • Humphrey Products Corporation
  • Dolomite Microfluidics
  • Cellix Ltd.
  • Christian BUrkert GmbH & Co. KG

Report Scope

In this report, the Global Microfluidic Components Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microfluidic Components Market, By Product

  • Valves (Solenoid Valves, Flow Control Valves, Check Valves, Shuttle Valves, Pressure Relief Valves, Proportional Valves, Other Valves)
  • Flow and Pressure Controllers
  • Flow and Pressure Sensors
  • Micropumps
  • Nozzles
  • Microneedles
  • Others

Microfluidic Components Market, By Industry

  • Oil & Gas
  • Healthcare
  • Aerospace & Defense
  • Consumer Electronics
  • Automotive
  • Other Industries

Microfluidic Components Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microfluidic Components Market.

Available Customizations:

Global Microfluidic Components Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microfluidic Components Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Valves (Solenoid Valves, Flow Control Valves, Check Valves, Shuttle Valves, Pressure Relief Valves, Proportional Valves, Other Valves), Flow and Pressure Controllers, Flow and Pressure Sensors, Micropumps, Nozzles, Microneedles, Others)
    • 5.2.2. By Industry (Oil & Gas, Healthcare, Aerospace & Defense, Consumer Electronics, Automotive, Other Industries)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Microfluidic Components Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Industry
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Microfluidic Components Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Industry
    • 6.3.2. Canada Microfluidic Components Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Industry
    • 6.3.3. Mexico Microfluidic Components Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Industry

7. Europe Microfluidic Components Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Industry
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Microfluidic Components Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Industry
    • 7.3.2. France Microfluidic Components Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Industry
    • 7.3.3. United Kingdom Microfluidic Components Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Industry
    • 7.3.4. Italy Microfluidic Components Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Industry
    • 7.3.5. Spain Microfluidic Components Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Industry

8. Asia Pacific Microfluidic Components Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Industry
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Microfluidic Components Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Industry
    • 8.3.2. India Microfluidic Components Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Industry
    • 8.3.3. Japan Microfluidic Components Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Industry
    • 8.3.4. South Korea Microfluidic Components Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Industry
    • 8.3.5. Australia Microfluidic Components Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Industry

9. Middle East & Africa Microfluidic Components Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Industry
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Microfluidic Components Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Industry
    • 9.3.2. UAE Microfluidic Components Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Industry
    • 9.3.3. South Africa Microfluidic Components Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Industry

10. South America Microfluidic Components Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Industry
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Microfluidic Components Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Industry
    • 10.3.2. Colombia Microfluidic Components Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Industry
    • 10.3.3. Argentina Microfluidic Components Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Industry

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Microfluidic Components Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Parker Hannifin Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. IDEX Corporation
  • 15.3. Fluigent SA
  • 15.4. Staiger GmbH & Co. KG
  • 15.5. SMC Corporation
  • 15.6. Camozzi Automation Spa Societa Unipersonale
  • 15.7. Aignep s.p.a.
  • 15.8. FIM Valvole Srl
  • 15.9. Humphrey Products Corporation
  • 15.10. Dolomite Microfluidics
  • 15.11. Cellix Ltd.
  • 15.12. Christian BUrkert GmbH & Co. KG

16. Strategic Recommendations

17. About Us & Disclaimer